ReviewHealth science reports2026
Comparing Non-Laboratory-Based and Laboratory-Based Cardiovascular Risk Predictions: Systematic Review and Meta-Analysis.
Review in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cardiovascular disease (CVD) remains the leading cause of global morbidity and mortality. This study assesses the agreement between non-laboratory-based and laboratory-based CVD risk equations across diverse settings. Methods: PubMed, Scopus, Web of Science, ProQuest Dissertations and Theses Global, and Google Scholar were systematically searched for studies published up to March 4, 2025. The protocol was registered with PROSPERO (CRD42021291936). Studies comparing laboratory-based and non-laboratory-based CVD risk equations were included, excluding those with participants who had CVD at baseline. A meta-analysis was conducted using mixed-effects meta-regression. The agreements for each study item (unit of analysis) were measured using the Spearman correlation coefficient and Kappa statistics. Results: A total of 33 studies, including 243,587 participants and nine CVD risk equations, were identified. The pooled Spearman correlation between the non-laboratory-based and laboratory-based equations was 0.954 (95% CI: 0.928-0.971, I Conclusion: Non-laboratory-based CVD risk equations demonstrate strong correlation and substantial agreement with laboratory-based equations. Non-laboratory-based CVD risk equations show strong concordance with laboratory-based equations in many settings; however, strong correlation and substantial agreement do not necessarily indicate predictive equivalence, and their interchangeability and implementation should be considered context-specific and require external validation and recalibration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.